AXQ Capital’s iRadimed IRMD Stock Holding History

AXQ Capital’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,334	Closed	-$227K	–	1121
2025 Q4	$227K	Buy	+2,334	New	+$200K	0.05%	528

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AXQ Capital's IRMD Position: Q1 2026 in Review

AXQ Capital sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 2,334 shares — an estimated $227K sold.

AXQ Capital first reported a position in IRMD in Q4 2025 and held it in 1 quarter. The position peaked at $227K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

AXQ Capital reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
AXQ Capital sold 2,334 iRadimed shares in Q1 2026, an estimated $227K.
AXQ Capital first reported a position in iRadimed in Q4 2025 and held it in 1 quarter.
AXQ Capital's iRadimed position peaked at $227K in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.